AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Price : 166.80 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 164.04 | 167.25 | 163.96 | 165.98 | 3.180M |
| Aug 20, 2026 | 163.40 | 165.57 | 161.48 | 164.49 | 5.094M |
| Aug 19, 2026 | 162.13 | 165.91 | 162.00 | 164.95 | 3.818M |
| Aug 18, 2026 | 159.12 | 160.64 | 158.98 | 160.10 | 3.002M |
| Aug 17, 2026 | 156.30 | 157.26 | 155.78 | 156.89 | 3.362M |
| Aug 14, 2026 | 155.50 | 156.46 | 154.53 | 156.45 | 3.698M |
| Aug 13, 2026 | 157.85 | 158.44 | 156.97 | 157.24 | 3.598M |
| Aug 12, 2026 | 157.68 | 159.02 | 157.12 | 158.50 | 4.140M |
| Aug 11, 2026 | 162.06 | 162.26 | 158.61 | 158.75 | 2.755M |
| Aug 10, 2026 | 160.59 | 162.72 | 160.25 | 161.91 | 3.746M |
| Aug 07, 2026 | 162.14 | 162.18 | 160.00 | 161.42 | 3.721M |
| Aug 06, 2026 | 162.62 | 162.93 | 159.75 | 161.07 | 2.354M |
| Aug 05, 2026 | 163.79 | 164.45 | 160.72 | 161.50 | 7.003M |
| Aug 04, 2026 | 157.95 | 158.56 | 155.32 | 155.62 | 8.095M |
| Aug 03, 2026 | 157.16 | 159.72 | 153.41 | 157.97 | 16.31M |
| Jul 31, 2026 | 170.53 | 170.74 | 168.44 | 169.64 | 1.670M |
| Jul 30, 2026 | 170.32 | 171.89 | 169.85 | 171.34 | 2.261M |
| Jul 29, 2026 | 174.24 | 175.04 | 172.63 | 173.30 | 2.252M |
| Jul 28, 2026 | 170.70 | 174.44 | 170.67 | 172.48 | 4.741M |
| Jul 27, 2026 | 170.08 | 173.24 | 167.79 | 169.64 | 3.861M |
| Jul 24, 2026 | 169.84 | 170.26 | 168.33 | 169.26 | 2.010M |
| Jul 23, 2026 | 166.37 | 169.49 | 166.04 | 168.27 | 2.394M |
| Jul 22, 2026 | 170.80 | 170.89 | 168.46 | 169.73 | 1.684M |
| Jul 21, 2026 | 165.35 | 169.43 | 164.82 | 169.34 | 1.986M |
| Jul 20, 2026 | 168.46 | 168.65 | 164.06 | 164.52 | 2.553M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GSK Plc | 51.79 |
| Johnson & Johnson | 273.05 |
| Eli Lilly & Co. | 1247.64 |
| Merck & Co., Inc. | 150.72 |
| Novo Nordisk A/S | 46.94 |
Price Related Metrics
| PE Ratio | 50.09 |
| PS Ratio | 8.611 |
| PEG Ratio | 1.473 |
| Price to Book Value | 10.93 |
| Price to Free Cash Flow | 64.68 |
| Earnings Yield | 2.00% |
| Market Cap | 517.36B |
| PEGY Ratio | 1.393 |
| Operating PE Ratio | 37.07 |
| Normalized PE Ratio | 49.51 |